| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/25/2023 | 28.21% | Barclays | $28 → $29 | Maintains | Overweight |
| 08/17/2023 | 23.78% | Evercore ISI Group | $25 → $28 | Maintains | Outperform |
| 07/06/2023 | 19.36% | Truist Securities | $28 → $27 | Maintains | Hold |
| 06/13/2023 | 6.1% | Wells Fargo | $25 → $24 | Maintains | Overweight |
| 04/20/2023 | -7.16% | Jefferies | → $21 | Initiates Coverage On | → Hold |
| 03/27/2023 | 10.52% | Evercore ISI Group | $27 → $25 | Maintains | Outperform |
| 03/24/2023 | 23.78% | Barclays | $36 → $28 | Maintains | Overweight |
| 03/16/2023 | 10.52% | Wells Fargo | $29 → $25 | Maintains | Overweight |
| 02/14/2023 | 41.47% | Baird | $31 → $32 | Maintains | Outperform |
| 01/04/2023 | -2.74% | Mizuho | $29 → $22 | Downgrades | Neutral → Underperform |
| 12/13/2022 | 59.15% | Barclays | $43 → $36 | Maintains | Overweight |
| 12/13/2022 | 28.21% | BMO Capital | → $29 | Initiates Coverage On | → Outperform |
| 11/22/2022 | 19.36% | Wells Fargo | $26 → $27 | Maintains | Overweight |
| 10/19/2022 | 28.21% | Mizuho | $31 → $29 | Maintains | Neutral |
| 10/18/2022 | 14.94% | Wells Fargo | $31 → $26 | Maintains | Overweight |
| 08/30/2022 | 37.05% | Wells Fargo | $33 → $31 | Maintains | Overweight |
| 07/20/2022 | 90.1% | Barclays | $48 → $43 | Maintains | Overweight |
| 07/06/2022 | 37.05% | Mizuho | $41 → $31 | Maintains | Neutral |
| 07/01/2022 | 45.89% | Wells Fargo | $45 → $33 | Maintains | Overweight |
| 07/01/2022 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 06/30/2022 | 45.89% | Truist Securities | $38 → $33 | Maintains | Hold |
| 04/22/2022 | 81.26% | Mizuho | → $41 | Initiates Coverage On | → Neutral |
| 12/01/2021 | 94.52% | Wells Fargo | $42 → $44 | Maintains | Overweight |
| 09/01/2021 | 112.2% | Barclays | → $48 | Initiates Coverage On | → Overweight |
| 04/14/2021 | 85.68% | Baird | → $42 | Upgrades | Neutral → Outperform |
| 01/22/2021 | 63.57% | Truist Securities | → $37 | Downgrades | Buy → Hold |
| 01/07/2021 | 54.73% | Baird | → $35 | Downgrades | Outperform → Neutral |
| 09/23/2020 | 54.73% | Wells Fargo | $37 → $35 | Maintains | Overweight |
| 05/06/2020 | 76.83% | Baird | $37 → $40 | Maintains | Outperform |
| 04/03/2020 | 54.73% | Stifel | $26 → $35 | Maintains | Buy |
| 09/19/2019 | 85.68% | Wells Fargo | $38 → $42 | Upgrades | Market Perform → Outperform |
| 09/10/2018 | -54.69% | B of A Securities | $10.5 → $10.25 | Maintains | Buy |
What is the target price for Cousins Props (CUZ)?
The latest price target for Cousins Props (NYSE: CUZ) was reported by Barclays on August 25, 2023. The analyst firm set a price target for $29.00 expecting CUZ to rise to within 12 months (a possible 28.21% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cousins Props (CUZ)?
The latest analyst rating for Cousins Props (NYSE: CUZ) was provided by Barclays, and Cousins Props maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Cousins Props (CUZ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cousins Props, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cousins Props was filed on August 25, 2023 so you should expect the next rating to be made available sometime around August 25, 2024.
Is the Analyst Rating Cousins Props (CUZ) correct?
While ratings are subjective and will change, the latest Cousins Props (CUZ) rating was a maintained with a price target of $28.00 to $29.00. The current price Cousins Props (CUZ) is trading at is $22.62, which is out of the analyst's predicted range.